NIH Cuts All COVID-19 Research Funding Following 'Pandemic Is Over' Declaration

The Trump administration has initiated significant cuts to COVID-19 research funding, terminating grants from the National Institutes of Health (NIH) and reallocating $11.4 billion in pandemic-related funds to focus on chronic diseases. The Department of Health and Human Services (HHS) declared the pandemic over, stating that the COVID-related grant funds are no longer necessary, leading to the cancellation of 29 awards aimed at developing antiviral treatments and vaccines. Critics argue that these cuts, particularly to programs like the Antiviral Drug Discovery Centers, are misguided and could hinder future pandemic preparedness. HHS Secretary Robert F. Kennedy Jr. emphasized a shift towards funding projects that align with the administration's health priorities, while experts express concern over the implications for public health research. The move highlights a broader trend of redefining federal funding priorities under the current administration, which also includes cutting support for research on various social and environmental issues. As the NIH adjusts its focus, many ongoing projects related to COVID-19 will be affected, raising alarms among public health advocates.